New drug STAR-0310 tested in healthy volunteers for first time
NCT ID NCT06782477
First seen Nov 05, 2025 · Last updated May 20, 2026 · Updated 23 times
Summary
This early-stage trial tests the safety of a new drug called STAR-0310 in 40 healthy adults. Participants receive a single dose of the drug or a placebo, and researchers monitor for side effects. The goal is to gather safety data, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Austin Clinical Research Unit - Early Clinical Development
Austin, Texas, 78744, United States
Conditions
Explore the condition pages connected to this study.